FDA grants AXS-05 Priority Review designation and sets PDUFA action goal date of April 30, 2026 NEW YORK, Dec. 31, 2025 ...

New Drug Application (NDA) submission on track for January 2026 NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Axsome ...

Peptides have long attracted attention in the scientific community due to their structural simplicity yet vast range of ...

Abstract: This paper investigates the frequency regulation problems of integrated renewable energy sources (RESs) power system under the non-ideal environment in open communication networks. Some ...

Stress is a part of everyday life. Chronic stress that persists over an extended period of time can lead to a higher risk of developing physical and mental health issues. Having a method to quantify ...

Wendy Wisner is a journalist and international board certified lactation consultant (IBCLC). She has written about all things pregnancy, maternal/child health, parenting, and general health and ...

And that you don’t decide “It’s Not for Me.” By Tony Maglio You probably aren’t a big fan of the new HBO Max price, but maybe this will make up for it? (Spoiler: it won’t.) On Wednesday, Oct. 22, HBO ...

Panelists discuss how the FDA-approved gemcitabine intravesical system (Inlexzo/TAR-200) represents a breakthrough in Bacillus Calmette-Guérin (BCG)-unresponsive bladder cancer treatment through its ...

GIPR/GLP-1R-targeting agents have demonstrated significant efficacy in appetite suppression and weight reduction; however, their adverse effect profiles and tolerability issues highlight the need for ...